Drug Prospectus
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Report of the International Narcotics Control Board for 2010
Report of the International Narcotics Control Board involving treatment for cocaine abuse accounted for 510. According to the 2009 AIDS Epidemic Update, 65 per cent of all cases involving treatment for published by the Joint United Nations Programme on substance abuse in 1998, and that figure decreased, in HIV/AIDS and WHO, an estimated 29 per cent of the relative terms, to 49 per cent in 2008. For the past more than 2 million Latin Americans who abuse drugs 10 years, cocaine has been the primary drug of abuse by injection are infected with HIV. HIV epidemics among persons treated for drug problems in the region. among such drug abusers in the region tend to be concentrated in the Southern Cone. It is estimated that 506. Demand for “crack” cocaine appears to be in Argentina alone, almost half of the persons who emerging in some countries in South America. In 2008, abuse drugs by injection are infected with HIV. seizures of “crack” cocaine were reported in Argentina, Brazil, Chile, Paraguay and Venezuela (Bolivarian Republic of). In the Bolivarian Republic of Venezuela, C. Asia lifetime prevalence of the abuse of “crack” cocaine among the population aged 15-70 is 11.9 per cent. In East and South-East Asia that country, about a quarter of the persons who received treatment for drug addiction were addicted to 1. Major developments “crack” cocaine. In 2010, the Government of Brazil launched its integrated plan to combat “crack” cocaine 511. In East and South-East Asia, progress in reducing and other drugs. opium production is under threat, owing to an upswing in opium poppy cultivation during the 2009 growing 507. -
Drug Trafficking in India: a Case for Border Security | 1
roximity to the largest producers of heroin and hashish-the Golden Triangle IDSA Occasional Paper No. 24 Pand Golden Crescent (Afghanistan-Pakistan-Iran) -has made India's border vulnerable to drug trafficking. Indigenous production of low grade heroin as well as various psychotropic and prescription drugs and their growing demand in the neighbouring countries and international market have added a new dimension to the problem of drug trafficking. Trends and patterns of drug trafficking in the country demonstrate that there is a gradual shift from traditional/natural drugs towards synthetic drugs that are being trafficked. Trafficking of drugs takes place overwhelmingly through land borders followed by sea and air routes. Given the vulnerability of the borders to drug trafficking, India has tried to tackle the problem through the strategy of drug supply and demand reduction, which involves enacting laws, co-operating with voluntary organisations, securing its borders and coasts by increasing surveillance, as well as seeking the active cooperation of its neighbours and the international community. Drug Trafficking Dr Pushpita Das is a Associate Fellow at the IDSA. She holds a Ph.D degree from the Jawahar Lal Nehru University. Her areas of interest in IDSA include Border Management, Coastal Security and the Northeast. in India: A Case for Border Security Institute for Defence Studies and Analyses Pushpita Das No.1, Development Enclave, Rao Tula Ram Marg, Delhi Cantt., New Delhi - 110 010 Tel.: (91-11) 2671-7983 Fax: (91-11) 2615 4191 E-mail: [email protected] Website: http://www.idsa.in Drug Trafficking in India: A Case for Border Security | 1 IDSA Occasional Paper No. -
Asia, International Drug Trafficking, and Us-China Counternarcotics
THE BROOKINGS INSTITUTION CENTER FOR NORTHEAST ASIAN POLICY STUDIES ASIA, INTERNATIONAL DRUG TRAFFICKING, AND U.S.-CHINA COUNTERNARCOTICS COOPERATION Zhang Yong-an Associate Professor and Associate Dean, College of Liberal Arts; and Executive Director, David F. Musto Center for Drug Policy Studies Shanghai University February 2012 THE BROOKINGS INSTITUTION 1775 Massachusetts Avenue, NW Washington D.C. 20036-2188 Tel: (202)797-6000 Fax: (202)797-2485 http://www.brookings.edu 1. Introduction The end of the Cold War may have heralded an end to certain tensions, but among other unforeseen effects it also precipitated a significant increase in the flow of illegal drugs across traditional national boundaries. International travel has become easier in an increasingly borderless world, and―although international drug trafficking organizations (DTOs) have never respected national boundaries―newly globalized markets for drug production and exportation, along with changing patterns of consumption in some societies, have had an enormous impact on drug trafficking. In short, the global market for illicit drugs, and the capacity of providers to deliver to this market, is expanding inexorably around the world. What was once called “the American disease”1 has become a global one. 2 The international community first took an interest in the Asian drug trade at the beginning of the 20th century. The Shanghai Opium Commission in 1909 was the first attempt at regulating drug trade in the region, as countries including the United States, Great Britain, China, Japan, and Russia convened to discuss the growing trafficking of opium. Since then, numerous measures have been adopted by individual countries and collectively to curb the illegal drug trade. -
Research Brief New Reports, Bills and Updates of Latest Research
Research Brief New reports, bills and updates of latest research Parliamentary Library and Information Service Department of Parliamentary Services ISSN 1836-7828 (Print) 1836-8050 (Online) Number 3 February 2014 Drugs, Poisons and Controlled Substances (Poppy Cultivation and Processing) Amendment Bill 2013 This Research Brief includes the following sections: Introduction .............................................................................................................. 1 1. Second Reading Speech ...................................................................................... 1 2. Background ........................................................................................................... 2 History of the Opium Poppy and the Poppy Industry ........................................................... 2 Development of the Tasmanian Poppy Industry ..................................................................... 3 Regulation of the Poppy Industry and the Thebaine Poppy .................................................. 5 The Tasmanian Poppy Industry Today and Processor Plans for Expansion ...................... 7 Expanding the Poppy Industry to Victoria ................................................................................ 8 3. The Bill ................................................................................................................... 9 4. Other Jurisdiction ............................................................................................. 11 Appendix 1. Description of Morphine, -
NOTIFICATION SPECIFYING SMALL QUANTITY and COMMERCIAL QUANTITYI Ly of the Pozoersconferred (Xxiiiil
NOTIFICATION SPECIFYING SMALL QUANTITY AND COMMERCIAL QUANTITYI ly of the pozoersconferred (xxiiiil . - lleyise by clansesfuiia) and of section2 of the Nnrcotic Drrtgsnnd pnlchotropic SrtbstancesAct, 19g5 (61 of 1985)and in supersessionof Ministry of Ftnnnce, (D Departmentof'Reuenue Noiification s.o.527 aotra i'6tt,1uli, tssi, exceptas respects things doneor omitted to be done .beforesuch supersession,the Cential Gooernmenihereby spectfiesthe qtnntitrl ,nlnt'ionedin coltnnnsS and 6 of the Tablebelow, in relationto.the narcoticdrug or psychotropicsubstnnce mentioned.ii tlr', ,1urrponding entnl in columns2 to 4 of thesaid Table,as the small quantitrl nnd commercialquantity respectiailyfor the purposesof the said clnuse:sof ttrit seciion. TABLE [Seesub-clause vii(a) and xxiii(a) of section 2 of the Act] Sl No. Name of Narcotic Drug and Other non-proprietary Chemical Name Small Commercial Psychotropic Substance name Quanti- Quantity (Intemational non-proprietary ity (in (in gm./kg.) name (INN) Acetorphine 3-0-acetyltetrahydro-7-alpha-(l-hydroxy-l- methylbutyt)-o, l4-endoetheno-onpavine $ 50 9.. 1\) Acetyl-alpha-methylfen N-[-(alpha-methylphenethyl)-4-piperidy]l acetanilide 0.1 g-. J. Acetyldihydrocodeine 100 4. Acetylmethadol 3-acetoxy-6-dimethylamino-4, 4 lheptane 50 gm. 5. Alfentanil -ethyl-4, N-[1-[2-( 5-dihydro-S-oxo-lH-tetrazol-t-yt) 01 gm. ethyll-4-(methoxymethyl)-4-piperidinyll -N- ylpropanamide Allyprodine 3-allyl Jmethyl-4-phenyl-4 Alpha-3-acetoxy-6-dimethylamino-4,Ld lheptane 100 gm Alpha-3-ethyl-l-methyl-4-phenyl-4-propionox 50 gm. 9.7' AlphamethadolArPnametnaool Alpha-6-dimethylamino-4, 4-diphenyl-3-heptanol 2 S0 gm. 10. Alphu-*"thylf"ntur,yl 11. -
Tennessee Drug Statutes Chart
Tennessee Drug Statutes Chart Tennessee Code: Title 39 Criminal Code SCHEDULE I OFFENSES/PENALTIES ENHANCEMENTS/ (*All sentences are for BENEFIT RESTRICTIONS standard offenders. Enhancement/mitigating factors may increase/reduce sentence. See sentencing statutes in appendix) 39-17-405 Criteria 39-17-417(b) (1) High potential for abuse; (2) Manufacture, delivery, No accepted med. Use in US or sale, possession w/ lacks accepted safety for med use intent (p.w.i.) of Schedule I Class B felony: 8-12yrs; <$100,000 39-17-406 Substances 3-17-417(i) Manufacture, (b) Opiates delivery, p.w.i. of heroin (c) Opium derivatives: E.g., (>15g); morphine heroin, codeine compounds, (>15g); hydromorphone morphine compounds, etc. (>5g); LSD (>5g); (d) Hallucinogenic substances: cocaine (>26g); E.g., MDMA, mescaline, DMT, pentazocine & peyote, LSD, psilocybin, synthetic tripelennamine (>5g); THC, etc. PCP (>30g); (e) Depressants: e.g., GHB, barbiturates (>100g); Qualuudes phenmetrazine (>50g); (f) Stimulants: E.g., fenethylline, amphetamine/ BZP methamphetamine (>26g); peyote (>1000g); Other Schedule I or II substances (>200g) Class B felony: 8-12yrs; <$200,000 SCHEDULE II 1 Tennessee Drug Statutes Chart Tennessee Code: Title 39 Criminal Code 39-17-407 Criteria 3-17-417(j) Manufacture, (1) high potential for abuse; (2) delivery, p.w.i. of heroin accepted med use in US w/ severe (>150g); morphine restrictions; and (3) abuse may (>150g); lead to severe psych or phys hydromorphone (>50g); dependence LSD (>50g); cocaine (>300g); pentazocine & tripelennamine (>50g); PCP (>300g); barbiturates (>1000g); phenmetrazine (>500g); amphetamine/ methamphetamine (>300g); peyote (>10000g); Other Schedule I or II substances (>2000g) Class A felony; 15-25yrs; <$500,000 39-17-408 Substances 39-17-417(c)(1) (b) Narcotics derived from Manufacture, delivery, vegetable origin or chemical p.w.i. -
Guns, Drugs, and Thugs Smuggling in the Golden Crescent
Guns, Drugs, and Thugs Smuggling in the Golden Crescent Michael Watson Michael Watson is from Richmond, Virginia and graduated from the University of Virginia in May of 2012 with a bachelor’s degree in History. He is currently pursuing his master’s in International Affairs with a concentration in Security Policy Studies. He is presently working for Charles Krauthammer as a researcher. Dr. Krauthammer is a syndicated columnist at the Washington Post, a Fox News contributor, and the author of New York Times best seller “Things That Matter.” Michael’s primary research interests are the Middle East and South Asia. ABSTRACT The Golden Crescent, which includes Afghanistan, Iran, and Pakistan, is one of the most important regions in the world for the global narcotics trade. Afghanistan’s poppy cultivation surged in the 1970s and it became a global supplier of opiates when other countries in the region banned poppies. Arms smuggling in Pakistan and Afghanistan traces back to resistance against British colonial rule, but the 1979 Soviet invasion of Afghanistan catalyzed the cross- border movement of weapons and narcotics in the region. Smugglers took advantage of preexisting routes and developed new ones during the 1980s to create the routes that are still in use today. Afghanistan’s prolific poppy fields now produce a massive outpouring of opiates that smugglers transport to European and other foreign markets. Traffickers use well- developed networks and techniques to convey narcotics from Afghanistan to Pakistan and Iran and precursor chemicals to heroin labs near the border through a combination of force, stealth, and corruption. Despite the Golden Crescent’s well-deserved reputation for narcotics, weapons trafficking predates the transnational drug trade, and entrepreneurial smugglers still provide the Taliban and other insurgent groups with firearms and heavier weapons. -
Narcotic Drugs Stupefiants Estupefacientes
E/INCB/1993/21Supp.6 INTERNATIONAL NARCOTICS CONTROL BOARD - VIENNA SUPPLEMENT No. 6 TO NARCOTIC DRUGS ESTIMATED WORLD REQUIREMENTS FOR 1994 STATISTICS FOR 1992 ESTIMATES UPDATED AS OF 30 JUNE 1994 ORGANE INTERNATIONAL DE CONTROLE DES STUPEFIANTS - VIENNE SUPPLEMENT N° 6 A r STUPEFIANTS EVALUATIONS DES BESOINS DU MONDE POUR 1994 STATISTIQUES POUR 1992 EVALUATIONS A JOUR AU 30 JUlN 1994 JUNTA INTERNACIONAL DE FISCALlZACION DE ESTUPEFACIENTES - VIENA SUPLEMENTO N.o 6 A ESTUPEFACIENTES PREVISIONES DE LAS NECESIDADES MUNDIALES PARA 1994 ESTADfsTICAS PARA 1992 PREVISIONES ACTUALlZADAS AL 30 DE JUNIO DE 1994 ~If..~~ ~ ~-tR UNITED NATIONS - NATIONS UNIES - NACIONES UNIDAS 1994 The updating of Table A is carried out by means of 12 monthly supplements. In order to facilitate the task of the exporting countries, the 12 supplements now report all the totals of the estimates and not only the amended data. In this way, each supplement cancels and replaces the published table in its entirety. In order to accelerate the transmission of the supplements to the competent national authorities, the 12 supplements will appear in English. Reading of these 12 supplements in French and Spanish may be facilitated by consulting the indexes of countries and territories and of narcotic drugs appearing in the annual publication. La mise El jour du tableau A s'effectue au moyen de douze supplements mensuels. Afin de faciliter la tache des pays exportateurs, les douze supplements contiennent tous les totaux des evaluations et non pas seulement les chiffres qui ont ete modifies. De celte maniere, chaque supplement annule et remplace entierement le tableau publie. -
Drug-Trafficking As a Non-Traditional Security Threat: Emerging Trends and Responses
Artha-Journal of Social Sciences 2019, Vol. 18, No. 4, 1-23 ISSN 0975-329X|https://doi: 10.12724/ajss.51.1 Drug-trafficking as a Non-traditional Security Threat: Emerging Trends and Responses Pushpita Das* Abstract India‟s proximity to two of the world‟s largest producers of opium and synthetic drugs and its large pharmaceutical base has made the country not only a conduit but also a source for drug trafficking. This illegal movement of narcotics and drugs pose significant threats to national security: breach of security of the international borders and the country, money generated by the sale of drugs and narcotics are used for terror funding and criminal groups engaged in drug trafficking develop nexus with terror networks. The trends and patterns of drug trafficking in the country demonstrate that there has been a gradual shift from traditional/natural drugs towards synthetic drugs that are being trafficked and consumed in the country. The paper analyses the steps taken by the State to curb the process and its effectiveness so far. Keywords: Drug Trafficking, National Security, Borders, Terror Funding, Anti-Drug Laws 1. Introduction While India has been facing the menace of drug trafficking for several decades, the problem has become acute in the past several years. The proximity of the country to two of the world‟s largest opium-producing areas- the golden crescent and the golden * Institute for Defence Studies and Analyses (IDSA), New Delhi, India; [email protected] 1 Artha-Journal of Social Sciences, Vol.18, No.4 ISSN 0975-329X triangle has made India a conduit as well as a destination for the narcotics and synthetic drugs produced there. -
Springmun 2018 United Nations Office on Drugs and Crime
SPRINGMUN 2018 UNITED NATIONS OFFICE ON DRUGS AND CRIME Letter from the Director Dear Delegates, I will be the chair of UNODC this year and I am extremely excited to be directing this committee. I am looking forward to see intellectual debate at this conference. My name is Amaan Amiri and I study in the 12th grade of Hill Spring International School. I am doing the IBDP program and I plan to go abroad and pursue international relations as my further education. I feel that it is extremely imperative that there is a friendly relationship between a chair and his delegates which is why I will tell you about a few interests of mine. Firstly, I was interested in MUN after my second MUN because I realised that by taking part in MUNs you can learn so much about the world and political issues by simply sitting in a committee room with other delegates. Debating and proving a point to other delegates is 1 something that always keep me going. My other hobbies include playing sports like football and basketball, playing a lot of video games and listening to music. I chose to discuss drug problems in Asia in UNODC, because the world’s focus has only been on Latin-American and not on Asia where the trafficking and abuse of opioids is rampant. This issue can be debated and analysed from a number of perspectives, and I hope that it will stimulate lively debate in committee. The threat that the golden crescent and the golden triangle poses is something that is underestimated by the global community and I believe this topic requires urgent discussion. -
Legal Opium Production for Medical Use in Mexico: Options, Practicalities and Challenges
LEGAL OPIUM PRODUCTION FOR MEDICAL USE IN MEXICO: OPTIONS, PRACTICALITIES AND CHALLENGES. SUMMARY: • Many countries legally grow opium for the production of opioid medicines - the scale of this market historically matching illegal opium production for non-medical uses • Legal opium production, imports and exports take place under the auspices of the 1961 UN drug convention, overseen by the UN International Narcotics Control Board (INCB) • Turkey and India have successfully managed transitions of traditional small scale illegal opium producers into a legal production model for medical uses within the UN system • There are no practical reasons why Mexico could not produce opium for domestic markets (helping address domestic shortages), or for export • Mexico would face different circumstances and unique local challenges - and such a transition would need to be carefully managed as part of a wider social development program • Legal opium production in Mexico for medical uses would, however, not affect N. American demand for illegal non-medical uses, and it is likely that illegal opium production would simply be displaced • Part of a longer term solution could see interests North and South of the Mexico/US border coordinated - in line with the ‘shared responsibility’ philosophy - with legal Mexican opium production supplying innovative harm reduction responses to the opioid crisis in North America (including medical prescribing of opium, hydromorphone & heroin) 1. LEGAL OPIUM PRODUCTION: BACKGROUND. production of poppy straw (China producing raw opium and poppy straw), concentrate of poppy straw (CPS), and extracted alkaloids. Australia, Opium is the latex or gum extracted from the France, India, Spain and Turkey are the five main opium poppy (Papaver somniferum). -
Narcotic Drugs — Estimated World Requirements for 2018
English — Comments COMMENTS ON THE REPORTED STATISTICS ON NARCOTIC DRUGS Part two Part Summary The further overall reduction in global stocks and in the production of opium confirm the con- Deuxi tinuing trend towards the eventual elimination of the drug from the international market for è opiate raw material. me partie Poppy straw and concentrate of poppy straw derived from the two main varieties of poppy straw (the morphine-rich and thebaine-rich varieties) decreased slightly in 2016 compared Segunda parte with 2015, and the manufacture of morphine remained stable at 422.1 tons, of which around 87 per cent of global manufacture was converted into other narcotic drugs or into substances not covered by the 1961 Convention. Of the remaining 13 per cent, only 8.6 per cent was directly consumed for palliative purposes. The differences in consumption levels between countries continued to be very significant. In 2016, 80 per cent of the world population consumed only 14 per cent of the total amount of morphine used for the management of pain and suffering. Although that represented an improvement on 2014, when 80 per cent of the world population consumed 9.5 per cent, the disparity in consumption of narcotic drugs for palliative care continues to be a matter of concern. After some fluctuations in the preceding years, global manufacture of thebaine reached the record level of 156 tons in 2016, signalling that the demand for medicines derived from thebaine, after having decreased in the past several years, appears to have resumed, despite restrictions on prescription drugs recently imposed in the main market (the United States of America) in response to their abuse and the high number of overdose deaths they have caused.